S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
LONDON - Legal & General (LON:LGEN) UCITS ETF PLC announced today that it will rename its L&G Healthcare Breakthrough UCITS ETF to L&G Healthcare Technology & Innovation UCITS ETF. The change is intended to better reflect the fund’s benchmark index, the ROBO Global® Healthcare Technology and Innovation Index TR.
The company confirmed that there will be no change to the benchmark index or the management approach of the fund. The name change is anticipated to be effective on or around May 15, 2025.
This move is a part of the company’s efforts to ensure that the fund’s name accurately represents its investment focus, facilitating clearer communication with investors regarding the fund’s underlying strategy.
The notice detailing the name change has been disseminated to the registered holder of shares in the sub-fund, which is the Bank of New York Mellon (NYSE:BK) (Depository) Nominees Limited. It has also been submitted to the National Storage Mechanism and will soon be available for public inspection.
Investors and interested parties can find more information and inspect the shareholder notice on the official websites listed in the press release.
The decision to rename the ETF comes as part of routine updates and reflects the company’s commitment to transparency and alignment with investment objectives. Legal & General Investment Management, the fund’s management firm, remains available for further inquiries via the contact information provided in the press release.
This article is based on a press release statement from Legal & General UCITS ETF PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.